v3.26.1
Note 3 - Equity - Schedule of Equity-Based Stock Warrants (Details) - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Outstanding, warrants (in shares) 1,934,874 287,231  
Outstanding, warrants, weighted average exercise price (in dollars per share) $ 5.89 $ 1.64  
Outstanding, warrants, weighted average remaining contractual term (Year) 5 years 21 days [1] 4 years 1 month 2 days 4 years 9 months 18 days
Outstanding, warrants, aggregate intrinsic value [2] $ 10,047 [1] $ 532,060 $ 17,072,147
Granted, warrants (in shares) 15,071,250 2,542,677  
Granted, warrants, weighted average exercise price (in dollars per share) $ 0.7 $ 4.31  
Exercised, warrants (in shares) (6,254,963) (892,432)  
Exercised, warrants, weighted average exercise price (in dollars per share) $ 0.41 $ 0.04  
Forfeited/Cancelled, warrants (in shares) (961) (2,602)  
Forfeited/Cancelled, warrants, weighted average exercise price (in dollars per share) $ 0.02 $ 0.2  
Exercisable, warrants (in shares)   1,842,889  
Exercisable, warrants, weighted average exercise price (in dollars per share)   $ 5.67  
Exercisable, warrants, weighted average remaining contractual term ( (Year)   4 years 21 days  
Exercisable, warrants, aggregate intrinsic value [2]   $ 532,060  
Outstanding, warrants (in shares) 10,750,200 [1] 1,934,874 287,231
Outstanding, warrants, weighted average exercise price (in dollars per share) $ 1.14 [1] $ 5.89 $ 1.64
[1] Amount includes 33,131 common warrants, 55,500 Series A Warrants, 1,477,596 Series B Warrants, 9,003,332 Series C Warrants and 180,641 Representative Warrants.
[2] Aggregate Intrinsic Value = Excess of market value over the exercise price of all in-the-money stock.